These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1832610

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK, White HD, Greaves SC.
    N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688
    [Abstract] [Full Text] [Related]

  • 24. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I, Spinler SA, Johnson NE.
    Ann Pharmacother; 1995 Feb 14; 29(7-8):743-59. PubMed ID: 8520093
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L, Bo M, Poli L, Zanocchi M, Fiandra U, Pedrazzini V, Fabris F.
    Recenti Prog Med; 1991 Mar 14; 82(3):155-62. PubMed ID: 2047557
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec 14; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 29. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B.
    Clin Ther; 1991 Dec 14; 13(4):500-10. PubMed ID: 1934003
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 14; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Apr 14; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A, Rovellini A, Fiorenza AM, Sommariva D.
    Int J Clin Pharmacol Ther; 1995 Jun 14; 33(6):345-50. PubMed ID: 7582386
    [Abstract] [Full Text] [Related]

  • 36. Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms.
    Owens D, Collins P, Johnson A, Tighe O, Robinson K, Tomkin GH.
    Biochim Biophys Acta; 1991 Apr 03; 1082(3):303-9. PubMed ID: 1903069
    [Abstract] [Full Text] [Related]

  • 37. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A, Jovell AJ, García-Altés A, García-Closas R, Serra-Majem L.
    Clin Ther; 1999 Nov 03; 21(11):1924-36. PubMed ID: 10890264
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R, Bovet P, Brunner HR, Bercher L.
    Schweiz Med Wochenschr; 1990 Jan 27; 120(4):85-91. PubMed ID: 2305221
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor simvastatin and the human lens. Clinical results of a 3-year follow-up.
    Behrens-Baumann W, Thiery J, Wieland E, Fieseler HG, Seidel D.
    Arzneimittelforschung; 1992 Aug 27; 42(8):1023-4. PubMed ID: 1418074
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.